| FANCC |
Homo sapiens |
|
FANCC is differentially expressed in 92 experiments [110 up/89 dn]: 31 organism parts: cerebellum [3 up/0 dn], liver [2 up/0 dn], ...; 24 disease states: normal [4 up/4 dn], breast carcinoma [1 up/1 dn], ...; 20 cell types, 21 cell lines, 17 compound treatments and 18 other conditions. |
| FAC, FACC, FANCC |
|
FANCC_RAT (Rattus norvegicus)
Fancc (Mus musculus)
(Compare orthologs)
|
|
|
| Fanconi anaemia group C protein |
|
|
| Fanconi anemia, complementation group C |
|
|
| cytosol, nucleus, protein binding, protein complex assembly |
|
|
|
Q00597
|
|
|
|
ENSG00000158169
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Normal
|
Disease state |
|
|
Epithelial cell
|
Cell type |
|
|
Stromal cell
|
Cell type |
|
|
Cerebellum
|
Organism part |
|
|
None
|
Compound treatment |
|
|
FLAP
|
Compound treatment |
|
|
HNRPA2B
|
Compound treatment |
|
|
MK886
|
Compound treatment |
|
|
Liver
|
Organism part |
|
|
Breast carcinoma
|
Disease state |
|
|
Skeletal muscle
|
Organism part |
|
|
Invasive ductal carcinoma
|
Histology |
|
|
Not applicable
|
Histology |
|
|
N/a
|
Test result |
|
|
Pan troglodytes
|
Organism |
|
|
BT-474
|
Cell line |
|
|
Homo sapiens
|
Organism |
|
|
Kidney
|
Organism part |
|
|
Pancreas
|
Organism part |
|
|
Acute promyelocytic leukemia
|
Disease state |
|
|
Lung
|
Organism part |
|
|
Adult
|
Developmental stage |
|
|
Control
|
Compound treatment |
|
|
HeLa
|
Cell line |
|
|
White blood cells
|
Organism part |
|
|
MDA-MB-231
|
Cell line |
|
|
Methotrexate
|
Compound treatment |
|
|
Adipose-derived stem cell
|
Cell type |
|
|
Chondrocyte
|
Cell type |
|
|
Acute malaria, natural infecti...
|
Disease state |
|
|
Vascular smooth muscle cell
|
Cell type |
|
|
Baseline uninfected
|
Disease state |
|
|
Tumor
|
Organism part |
|
|
HPL1
|
Cell line |
|
|
Spermatocyte
|
Cell type |
|
|
Testis
|
Organism part |
|
|
Spermatid
|
Cell type |
|
|
Skin
|
Organism part |
|
|
Frontal cortex, superior motor...
|
Organism part |
|
|
Superior cervical ganglion
|
Organism part |
|
|
BT474
|
Cell line |
|
|
Cartilage
|
Organism part |
|
|
Macaca mulatta
|
Organism |
|
|
Seminiferous tubule
|
Organism part |
|
|
Peripheral blood
|
Organism part |
|
|
SW480
|
Cell line |
|
|
SW620
|
Cell line |
|
|
HaCaT
|
Cell line |
|
|
Bacterial endotoxin
|
Compound treatment |
|
|
Kidney cell
|
Cell type |
|
|
Glioblastoma
|
Disease state |
|
|
Grade IV
|
Tumor grading |
|
|
Training set
|
Population |
|
|
Test set
|
Population |
|
|
Epilepsy
|
Disease state |
|
|
Smooth muscle
|
Organism part |
|
|
Experimental malaria-infected
|
Disease state |
|
|
Epidermal growth factor
|
Compound treatment |
|
|
Plasmacytoid dendritic cell
|
Cell type |
|
|
Whole blood
|
Organism part |
|
|
Trigeminal ganglion
|
Organism part |
|
|
Fetal bovine serum in media
|
Growth condition |
|
|
Gastric cancer
|
Disease state |
|
|
Control for heregulin
|
Compound treatment |
|
|
T3aN1M0
|
Disease staging |
|
|
Superficial transitional cell ...
|
Disease state |
|
|
Heat-killed HL60 cell lysate
|
Infection |
|
|
Ciliary ganglion
|
Organism part |
|
|
Benign prostatic hyperplasia
|
Disease state |
|
|
Prostate carcinoma
|
Disease state |
|
|
Primary cells
|
Cell line |
|
|
PC3
|
Cell line |
|
|
Frontal cortex, primary motor ...
|
Organism part |
|
|
Dorsal root ganglion
|
Organism part |
|
|
Trichostatin A
|
Compound treatment |
|
|
Johnsen score count 3.2: Serto...
|
Histology |
|
|
T47D
|
Cell line |
|
|
Teratozoospermia
|
Disease state |
|
|
Normospermic
|
Disease state |
|
|
Blood
|
Organism part |
|
|
Umbilical cord
|
Organism part |
|
|
Fetus
|
Developmental stage |
|
|
Pons
|
Organism part |
|
|
Primary gastric tumor
|
Organism part |
|
|
0 cm away from the tumor bound...
|
Observation |
|
|
MCF-7
|
Cell line |
|
|
T3aNxM1
|
Disease staging |
|
|
A549
|
Cell line |
|
|
U937
|
Cell line |
|
|
Control
|
RNAi |
|
|
SIM2s
|
RNAi |
|
|
HL-60
|
Cell line |
|
|
U87
|
Cell line |
|
|
U373
|
Cell line |
|
|
Dermal fibroblast
|
Cell type |
|
|
CodeLink Labeling
|
Protocol type |
|
|
PCep4 control vector transfect...
|
Gene modification |
|
|
ETat plasmid transfection
|
Gene modification |
|
|
Leydig cell
|
Cell type |
|
|
Mononuclear cell
|
Cell type |
|
|
Affymetrix Labeling
|
Protocol type |
|
|
Endometrioid carcinoma
|
Disease state |
|
|
Hypericin incubated, not irrad...
|
Growth condition |
|
|
Hypericin incubated, irradiate...
|
Growth condition |
|
|
Atrioventricular node
|
Organism part |
|
|
Treated malaria, natural infec...
|
Disease state |
|
|
Chronic lymphocytic leukemia
|
Disease state |
|
|
ERalpha/beta transfected
|
Genotype |
|
|
Caudate nucleus
|
Organism part |
|
|
Lymphatic endothelial cell
|
Cell type |
|
|
White blood cell
|
Cell type |
|
|
Platelet
|
Cell type |
|
|
T3aN0Mx
|
Disease staging |
|
|
SkinEthic keratinocyte
|
Cell type |
|
|
Epidermal keratinocyte
|
Cell type |
|
|
Geriatric
|
Developmental stage |
|
|
Pediatric
|
Developmental stage |
|
|
Caco-2
|
Cell line |
|
|
Beta cell islets
|
Organism part |
|
|
Monoclonal gammopathy of undet...
|
Disease state |
|
|
IgV status unknown
|
Genotype |
|
|
Metastatic
|
Disease staging |
|
|
17-allylamino-geldanamycin
|
Compound treatment |
|
|
Unknown_sex
|
Sex |
|
|
MCF10A
|
Cell line |
|
|
T47-D
|
Cell line |
|
|
DMSO
|
Vehicle |
|
|
Rheumatoid arthritis
|
Disease state |
|
|
Stage I
|
Disease staging |
|
|
T1bN0M0
|
Disease staging |
|
|
Glioblastoma with EGFR amplifi...
|
Disease state |
|
|
IgV unmutated
|
Genotype |
|
|
Idiopathic dilated cardiomyopa...
|
Disease state |
|
|
Oligodendroglioma with 1p19q c...
|
Disease state |
|
|
Organism_part
|
Material type |
|
|
Cell
|
Material type |
|
|
Primary fibroblast
|
Cell type |
|
|
Spinal cord
|
Organism part |
|
|
Idiopathic cardiomyopathy
|
Disease state |
|
|
R-(-)-apomorphine HCl
|
Compound treatment |
|
|
Salivary gland
|
Organism part |
|
|
Carboplatin resistant
|
Test result |
|
|
Carboplatin sensitive
|
Test result |
|
|
Infant
|
Developmental stage |
|
|
Interferon-gamma + lipopolysac...
|
Compound treatment |
|
|
Cyclosporin A, mycophenolate m...
|
Clinical treatment |
|
|
Sirolimus, mycophenolate mofet...
|
Clinical treatment |
|
|
Ovary
|
Organism part |
|
|
5-aza-2'-deoxycytidine + trich...
|
Compound treatment |
|
|
Nocodazole
|
Compound treatment |
|
|
Hydroxyurea
|
Compound treatment |
|
|
GLI60
|
Cell line |
|
|
Tissue culture polystyrene dis...
|
Growth condition |
|
|
Collagen/chondroitin tissue en...
|
Growth condition |
|
|
Estrogen receptor 1 positive; ...
|
Test result |
|
|
Plasma cell leukemia
|
Disease state |
|
|
Astrocyte
|
Cell type |
|
|
Female
|
Sex |
|
|
Male
|
Sex |
|
|
Johnsen score count 7: many ea...
|
Histology |
|
|
Johnsen score count 8: hypospe...
|
Histology |
|
|
Endothelial cell
|
Cell type |
|
|
Granulocyte-colony stimulating...
|
Compound treatment |
|
|
|
|
|
Processing time: 0.127 secs.